• Dr. Anushika Luckmy Solanga Arachchige Post graduate trainee in Respiratory Medicine, Postgraduate Insititute of Medicine, Colombo, Sri Lanka
  • Dushantha Madegedara Chair Professor of Medicine, Wayamba University of Sri Lanka and Consultant Respiratory Physician, Respiratory Disease Treatment Unit, National Hospital, Kandy, Sri Lanka.



Clinical Characteristics, Community Acquired Pneumonia, Outcome

Abstract [English]

Introduction and Objective:
Community acquired pneumonia (CAP) is associated with increased mortality and morbidity. The disease severity is multifactorial, co-morbid conditions and advanced age are the most important risk factors. At present, there is a sparsity in published data on CAP in Sri Lankan adults and adolescents. Aim of study to identify complications and outcome of CAP.
A single center descriptive prospective study was carried out in Respiratory Unit 11 in National Hospital-Kandy, Sri Lanka, among diagnosed CAP patients during six months from 1st of September 2020 to 28th of February 2021. Data were analyzed by SPSS (Statistical Package for Social Sciences) 21 package.
105 cases were analyzed; of which 35.2% had complications. Parapenumonic effusion was the commonest complication, whilst pyothorax was the rarest complication. Nine patients (24%) had multiple complications. Prevalence of complications significantly correlated with CURB 65 score (pearson correlation coefficient 0.57, p value 0.001).
93.3% of patients survived with treatment, however 6.6% of them demised with male predominance and all had at least 2 preexisting diseases. Five deaths (71.4%) occurred in the intensive care unit. During follow up, 3.8% were diagnosed with bronchial malignancy, 5.7% pulmonary tuberculosis, 2.8% other chronic infections (melioidosis) and 1.9% chronic organizing pneumonia, respectively.
CAP is a major health concern in central Sri Lanka during COVID-19 pandemic. Most CAP patients recovered completely. Mortality 6.6% with male predominance. Parapneumonic effusion was the commonest complication. Number of Complications had significant correlation with CURB 65 score


Download data is not yet available.


Eekholm, S., Ahlström, G., Kristensson, J., & Lindhardt, T. (2020). Gaps Between Current Clinical Practice and Evidence-Based Guidelines for Treatment and Care of Older Patients with Community Acquired Pneumonia: A Descriptive Cross-Sectional Study. BMC Infectious Diseases, 20(1), 73. DOI:

Eshwara, V. K., Mukhopadhyay, C., & Rello, J. (2020). Community-Acquired Bacterial Pneumonia in Adults: An Update. Indian Journal of Medical Research, 151(4), 287–302. DOI:

Ewig, S., Höffken, G., Kern, W. V., Rohde, G., Flick, H., Krause, R., Ott, S., Bauer, T., Dalhoff, K., Gatermann, S., Kolditz, M., Krüger, S., Lorenz, J., Pletz, M., de Roux, A., Schaaf, B., Schaberg, T., Schütte, H., & Welte, T. (2016). Behandlung Von Erwachsenen Patienten Mit Ambulant Erworbener Pneumonie und Prävention - Update 2016 [Management of Adult Community-acquired Pneumonia and Prevention - Update 2016]. Pneumologie (Stuttgart, Germany), 70(3), 151–200. DOI:

Fauci, A. S. (Ed.). (1998). Harrison’s Principles of Internal Medicine. McGraw-Hill.

Haniffa, R., Ariyaratne, H., Fernando, S., & Rajapakse, S. (2009). Initial management of Patients With Community-Acquired Pneumonia in a Tertiary Hospital in Sri Lanka. Sri Lanka Journal of Critical Care, 1(1), 32–34. DOI:

Health Government (2023).

Ishiguro, T., Takayanagi, N., Yamaguchi, S., Yamakawa, H., Nakamoto, K., Takaku, Y., Miyahara, Y., Kagiyama, N., Kurashima, K., Yanagisawa, T., & Sugita, Y. (2013). Etiology and Factors Contributing to the Severity and Mortality of Community-Acquired Pneumonia. Internal Medicine (Tokyo, Japan), 52(3), 317–324. DOI:

Ishiguro, T., Yoshii, Y., Kanauchi, T., Hoshi, T., Takaku, Y., Kagiyama, N., Kurashima, K., & Takayanagi, N. (2018). Re-Evaluation of the Etiology and Clinical and Radiological Features of Community-Acquired Lobar Pneumonia in Adults. Journal of Infection and Chemotherapy: Official Journal of the Japan Society of Chemotherapy, 24(6), 463–469. DOI:

Jahanihashemi, H., Babaie, M., Bijani, S., Bazzazan, M., & Bijani, B. (2018). Poverty as an Independent Risk Factor for in-Hospital Mortality in Community-Acquired Pneumonia: A Study in a Developing Country Population. International Journal of Clinical Practice, 72(5), e13085. DOI:

Kudagammana, S. T., Karunaratne, R. R., Munasinghe, T. S., & Kudagammana, H. D. W. S. (2020). Community Acquired Paediatric Pneumonia; Experience from a Pneumococcal Vaccine- Naive Population. Pneumonia, 12, 8. DOI:

Lim, W. S., Baudouin, S. V., George, R. C., Hill, A. T., Jamieson, C., Le Jeune, I., Macfarlane, J. T., Read, R. C., Roberts, H. J., Levy, M. L., Wani, M., Woodhead, M. A., (2009). Pneumonia Guidelines Committee of the BTS Standards of Care Committee. BTS Guidelines for the Management of Community Acquired Pneumonia in Adults: Update 2009. Thorax, 64, Suppl. 3, iii1–ii55. DOI:

Lim, W. S., Van Der Eerden, M. M., Laing, R., Boersma, W. G., Karalus, N., Town, G. I., Lewis, S. A., & Macfarlane, J. T. (2003). Defining Community Acquired Pneumonia Severity on Presentation to Hospital: An International Derivation and Validation Study. Thorax, 58(5), 377–382. DOI:

Mandell, L. A., Wunderink, R. G., Anzueto, A., Bartlett, J. G., Campbell, G. D., Dean, N. C., Dowell, S. F., File, T. M., Jr., Musher, D. M., Niederman, M. S., Torres, A., Whitney, C. G. (2007). Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-Acquired Pneumonia in Adults. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America, 44, Suppl. 2(Suppl 2), S27–S72. DOI:

Mbata, G., Chukwuka, C., Onyedum, C., Onwubere, B., & Aguwa, E. (2013). The Role of Complications of Community Acquired Pneumonia on the Outcome of the Illness: A Prospective Observational Study in a Tertiary Institution In Eastern Nigeria. Annals of Medical and Health Sciences Research, 3(3), 365–369. DOI:

Mishra, A. B., & Behera, G. B. (2016). Community Acquired Pneumonia, Detection and Prevention-A Hospital Based Descriptive Study. International Journal of Contemporary Medical Research, 3(4), 1127–1129.

Murray, C. J. L., & Lopez, A. D. (2013). Measuring the Global Burden of Disease. New England Journal of Medicine, 369(5), 448–457. DOI:

Myint, P. K., Kwok, C. S., Majumdar, S. R., Eurich, D. T., Clark, A. B., España, P. P., Man, S. Y., Huang, D. T., Yealy, D. M., Angus, D. C., Capelastegui, A., Rainer, T. H., Marrie, T. J., Fine, M. J., & Loke, Y. K. (2012). The International Community-Acquired Pneumonia (CAP) Collaboration Cohort (ICCC) Study: Rationale, Design and Description of Study Cohorts and Patients. BMJ Open, 2(3), e001030. DOI:

Partouche, H., Buffel du Vaure, C., Personne, V., Le Cossec, C., Garcin, C., Lorenzo, A., Ghasarossian, C., Landais, P., Toubiana, L., & Gilberg, S. (2015). Suspected Community-Acquired Pneumonia in an Ambulatory Setting (CAPA): A French Prospective Observational Cohort Study in General Practice. npj Primary Care Respiratory Medicine, 25, 15010. DOI:

Peto, L., Nadjm, B., Horby, P., Ngan, T. T., van Doorn, R., Van Kinh, N., & Wertheim, H. F. (2014). The Bacterial Aetiology of Adult Community-Acquired Pneumonia in Asia: A Systematic Review. Transactions of the Royal Society of Tropical Medicine and Hygiene, 108(6), 326–337. DOI:

Sabatier, C., Peredo, R., Villagrá, A., Bacelar, N., Mariscal, D., Ferrer, R., Gallego, M., & Vallés, J. (2010). Neumonía Comunitaria Grave. Estudio Descriptivo De 7 Años y Utilidad de los Criterios de la Infectious Diseases Society of America y la American Thoracic Society 2007 en la identificación de los pacientes que requieren ingreso en una unidad de cuidados intensivos. Medicina Intensiva, 34(4), 237–245. DOI:

Self, W. H., Balk, R. A., Grijalva, C. G., Williams, D. J., Zhu, Y., Anderson, E. J., Waterer, G. W., Courtney, D. M., Bramley, A. M., Trabue, C., Fakhran, S., Blaschke, A. J., Jain, S., Edwards, K. M., & Wunderink, R. G. (2017). Procalcitonin as a Marker of Etiology in Adults Hospitalized with Community-Acquired Pneumonia. Clinical Infectious Diseases, 65(2), 183–190. DOI:

Sample Size Calculator (2023).

Shah, B. A., Singh, G., Naik, M. A., & Dhobi, G. N. (2010). Bacteriological and Clinical Profile of Community Acquired Pneumonia in Hospitalized Patients. Lung India: Official Organ of Indian Chest Society, 27(2), 54–57. DOI:

Sri Lanka Labour Force Annual Report (2019).

Torres, A., Cillóniz, C., Blasi, F., Chalmers, J. D., Gaillat, J., Dartois, N., Schmitt, H. J., & Welte, T. (2018). Burden of Pneumococcal Community-Acquired Pneumonia in Adults Across Europe: A literature Review. Respiratory Medicine, 137, 6–13. DOI:

Torres-Duque, C., Maldonado, D., Pérez-Padilla, R., Ezzati, M., Viegi, G., & Forum of International Respiratory Studies (FIRS) Task Force on Health Effects of Biomass Exposure. (2008). Biomass Fuels and Respiratory Diseases: A Review of the Evidence. Proceedings of the American Thoracic Society, 5(5), 577–590. DOI:

Wijesooriya, L. I., Kok, T., Perera, J., Tilakarathne, Y., & Sunil-Chandra, N. P. (2018). Mycoplasma Pneumoniae DNA Detection and Specific Antibody class Response in Patients from Two Tertiary Care Hospitals in Tropical Sri Lanka. Journal of Medical Microbiology, 67(9), 1232–1242. DOI:

Xing, Y. F., Xu, Y. H., Shi, M. H., & Lian, Y. X. (2016). The Impact of PM2.5 on the Human Respiratory System. Journal of Thoracic Disease, 8(1), E69–E74.




How to Cite